ARCHIVES

Bristol-Myers, Karolinska In Collaboration For Studies.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Yates Identifies “Probable”, “Potential” Core Grant Applicants

January 16, 1987

Garb’s Questions, Answers About Cancer Program

December 12, 1980

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999

NCAB Needs Focus, Strong Membership To Better Advise NCI, Chairman Rimer Says

September 22, 1995

NCI Extramural Program: Advisors Approve Concepts For Diagnostic Imaging Trials Group

March 21, 1997

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008